Dysglycemia and Cardiometabolic Risk: Pathophysiological Rationale and the Emerging Role of Nutraceuticals in Integrated Prevention
Arrigo Francesco Giuseppe Cicero(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Annamaria Colao(Federico II University Hospital), Alessandro D. Genazzani(University of Modena and Reggio Emilia), Giovanni Scapagnini(University of Molise), Andrea Zanchè(Azienda USL di Pescara), Giuseppe Marazzi(Sapienza University of Rome), Davide Grassi(University of L'Aquila), Roberta Scairati(Ollscoil na Gaillimhe – University of Galway)
Cited by 0
Related Papers
The Vaginal Microbiome: A Long Urogenital Colonization Throughout Woman Life
|Frontiers in Cellular and Infection Microbiology|2021|118
Caloric Restriction Mimetics in Nutrition and Clinical Trials
|Frontiers in Nutrition|2021|109
The Interplay Between Prolactin and Reproductive System: Focus on Uterine Pathophysiology
|Frontiers in Endocrinology|2020|71
Metabolic syndrome in the era of COVID-19 outbreak: impact of lockdown on cardiometabolic health
|Journal of Endocrinological Investigation|2021|33
Dietary Flavonoids and Adult Neurogenesis: Potential Implications forBrain Aging
|Current Neuropharmacology|2022|26